Status:
ACTIVE_NOT_RECRUITING
Low Intensity Focused Ultrasound Modulation of Thalamic Nuclei for Central Neuropathic Pain.
Lead Sponsor:
University of Sao Paulo
Conditions:
Central Neuropathic Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
LIFUP may have a modulatory effect on neuronal circuitry involved in pain, specifically when applied to the anterior thalamic nuclei, which is an important part of the pain circuit .Precise laboratory...
Detailed Description
Chronic pain (CP) is highly prevalent worldwide and has been identified as a major public health problem in many countries (1), being one of the ten leading causes of years lived with disability. CP h...
Eligibility Criteria
Inclusion
- Male or female more than 18 years old;
- Persistent presence of pain from braquial plexopathy injury for more than 3 months with an average of pain scoring of four or more points in numeric verbal scale (refractory to treatments).
Exclusion
- history of uncontrolled epilepsy
- history of depression
- surgery or hospitalizations in the last 6 months
- presence of metal brain implants
- history of alcohol or drug addiction
- pregnancy
- history of loss of consciousness lasting more than 15 minutes
Key Trial Info
Start Date :
November 19 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 25 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06978764
Start Date
November 19 2024
End Date
April 25 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurology Department HCFMUSP
São Paulo, São Paulo, Brazil, 05403000